Literature DB >> 10380706

The HLA-A*6601 peptide motif: prediction by pocket structure and verification by peptide analysis.

F H Seeger1, M Schirle, J Gatfield, D Arnold, W Keilholz, P Nickolaus, H G Rammensee, S Stevanović.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10380706     DOI： 10.1007/s002510050539

Source DB:  PubMed          Journal:  Immunogenetics        ISSN： 0093-7711            Impact factor:   2.846


× No keyword cloud information.
  8 in total

1.  Predicting sequences and structures of MHC-binding peptides: a computational combinatorial approach.

Authors:  J Zen; H R Treutlein; G B Rudy
Journal:  J Comput Aided Mol Des       Date:  2001-06       Impact factor: 3.686

2.  Peptide-binding motif of HLA-A*6603.

Authors:  Christina Bade-Doeding; Britta Eiz-Vesper; Constanca Figueiredo; Axel Seltsam; Holger-Andreas Elsner; Rainer Blasczyk
Journal:  Immunogenetics       Date:  2004-12-08       Impact factor: 2.846

3.  Naturally presented peptides on major histocompatibility complex I and II molecules eluted from central nervous system of multiple sclerosis patients.

Authors:  Nicolas Fissolo; Sabrina Haag; Katrien L de Graaf; Oliver Drews; Stefan Stevanovic; Hans Georg Rammensee; Robert Weissert
Journal:  Mol Cell Proteomics       Date:  2009-06-16       Impact factor: 5.911

4.  The peptide-binding specificity of HLA-A*3001 demonstrates membership of the HLA-A3 supertype.

Authors:  Kasper Lamberth; Gustav Røder; Mikkel Harndahl; Morten Nielsen; Claus Lundegaard; Claus Schafer-Nielsen; Ole Lund; Soren Buus
Journal:  Immunogenetics       Date:  2008-09-04       Impact factor: 2.846

5.  HLA-DR-presented peptide repertoires derived from human monocyte-derived dendritic cells pulsed with blood coagulation factor VIII.

Authors:  Simon D van Haren; Eszter Herczenik; Anja ten Brinke; Koen Mertens; Jan Voorberg; Alexander B Meijer
Journal:  Mol Cell Proteomics       Date:  2011-04-05       Impact factor: 5.911

6.  Identification and characterization of human leukocyte antigen class I ligands in renal cell carcinoma cells.

Authors:  Barbara Seliger; Sven P Dressler; Chiara Massa; Christian V Recktenwald; Florian Altenberend; Juergen Bukur; Francesco M Marincola; Ena Wang; Stefan Stevanovic; Rudolf Lichtenfels
Journal:  Proteomics       Date:  2011-05-18       Impact factor: 3.984

7.  A single amino-acid polymorphism in pocket A of HLA-A*6602 alters the auxiliary anchors compared with HLA-A*6601 ligands.

Authors:  Christina Bade-Doeding; Holger-Andreas Elsner; Britta Eiz-Vesper; Axel Seltsam; Ute Holtkamp; Rainer Blasczyk
Journal:  Immunogenetics       Date:  2004-04-30       Impact factor: 2.846

8.  MHC class I loaded ligands from breast cancer cell lines: A potential HLA-I-typed antigen collection.

Authors:  Dmitri V Rozanov; Nikita D Rozanov; Kami E Chiotti; Ashok Reddy; Phillip A Wilmarth; Larry L David; Seung W Cha; Sunghee Woo; Pavel Pevzner; Vineet Bafna; Gregory G Burrows; Juha K Rantala; Trevor Levin; Pavana Anur; Katie Johnson-Camacho; Shaadi Tabatabaei; Daniel J Munson; Tullia C Bruno; Jill E Slansky; John W Kappler; Naoto Hirano; Sebastian Boegel; Bernard A Fox; Colt Egelston; Diana L Simons; Grecia Jimenez; Peter P Lee; Joe W Gray; Paul T Spellman
Journal:  J Proteomics       Date:  2018-01-10       Impact factor: 4.044
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.